How the Advanced Therapy Medicinal Products CDMO Market Supports Advanced Biologic Development
The demand for Advanced Therapy Medicinal Products CDMO Market is surging, driven by rising investments in cell and gene therapies. The market is projected to grow from USD 29.97 million in 2024 to USD 134.73 million by 2035, marking a compound annual growth rate (CAGR) of 14.64%. Such significant growth reflects a broader shift towards personalized medicine and innovative therapeutic...
0 Comments 0 Shares 312 Views 0 Reviews